SrasV1, PubMed, Corpus, bibRecord, 001802

Unraveling the complexities of the interferon response during SARS-CoV infection.

Identifieur interne : 001802 ( PubMed/Corpus ); précédent : 001801; suivant : 001803

Unraveling the complexities of the interferon response during SARS-CoV infection.

Auteurs : Anna De Lang ; Tracey Baas ; Saskia L. Smits ; Michael G. Katze ; Albert Dme Osterhaus ; Bart L. Haagmans

Source :

Future virology [ 1746-0794 ] ; 2009.

RBID : pubmed:19885368

Abstract

Viruses employ different strategies to circumvent the antiviral actions of the innate immune response. SARS coronavirus (SARS-CoV), a virus that causes severe lung damage, encodes an array of proteins able to inhibit induction and signaling of type-I interferons. However, recent studies have demonstrated that interferons are produced during SARS-CoV infection in humans and macaques. Furthermore, nuclear translocation of activated STAT1 and a range of interferon-stimulated genes could be demonstrated in the lungs of SARS-CoV-infected macaques. In line with these observations, plasmacytoid dendritic cells have been shown to produce interferons upon SARS-CoV infection in vitro. Given the pivotal role of interferons during viral infections, (differential) induction of interferons may affect the outcome of the infection. Therefore, the functional implication of interferon production during SARS-CoV infection remains to be re-investigated.

DOI: 10.2217/17460794.4.1.71
PubMed: 19885368

Links to Exploration step

pubmed:19885368

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unraveling the complexities of the interferon response during SARS-CoV infection.</title>
<author><name sortKey="De Lang, Anna" sort="De Lang, Anna" uniqKey="De Lang A" first="Anna" last="De Lang">Anna De Lang</name>
<affiliation><nlm:affiliation>Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Baas, Tracey" sort="Baas, Tracey" uniqKey="Baas T" first="Tracey" last="Baas">Tracey Baas</name>
</author>
<author><name sortKey="Smits, Saskia L" sort="Smits, Saskia L" uniqKey="Smits S" first="Saskia L" last="Smits">Saskia L. Smits</name>
</author>
<author><name sortKey="Katze, Michael G" sort="Katze, Michael G" uniqKey="Katze M" first="Michael G" last="Katze">Michael G. Katze</name>
</author>
<author><name sortKey="Osterhaus, Albert Dme" sort="Osterhaus, Albert Dme" uniqKey="Osterhaus A" first="Albert Dme" last="Osterhaus">Albert Dme Osterhaus</name>
</author>
<author><name sortKey="Haagmans, Bart L" sort="Haagmans, Bart L" uniqKey="Haagmans B" first="Bart L" last="Haagmans">Bart L. Haagmans</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19885368</idno>
<idno type="pmid">19885368</idno>
<idno type="doi">10.2217/17460794.4.1.71</idno>
<idno type="wicri:Area/PubMed/Corpus">001802</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001802</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Unraveling the complexities of the interferon response during SARS-CoV infection.</title>
<author><name sortKey="De Lang, Anna" sort="De Lang, Anna" uniqKey="De Lang A" first="Anna" last="De Lang">Anna De Lang</name>
<affiliation><nlm:affiliation>Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Baas, Tracey" sort="Baas, Tracey" uniqKey="Baas T" first="Tracey" last="Baas">Tracey Baas</name>
</author>
<author><name sortKey="Smits, Saskia L" sort="Smits, Saskia L" uniqKey="Smits S" first="Saskia L" last="Smits">Saskia L. Smits</name>
</author>
<author><name sortKey="Katze, Michael G" sort="Katze, Michael G" uniqKey="Katze M" first="Michael G" last="Katze">Michael G. Katze</name>
</author>
<author><name sortKey="Osterhaus, Albert Dme" sort="Osterhaus, Albert Dme" uniqKey="Osterhaus A" first="Albert Dme" last="Osterhaus">Albert Dme Osterhaus</name>
</author>
<author><name sortKey="Haagmans, Bart L" sort="Haagmans, Bart L" uniqKey="Haagmans B" first="Bart L" last="Haagmans">Bart L. Haagmans</name>
</author>
</analytic>
<series><title level="j">Future virology</title>
<idno type="ISSN">1746-0794</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Viruses employ different strategies to circumvent the antiviral actions of the innate immune response. SARS coronavirus (SARS-CoV), a virus that causes severe lung damage, encodes an array of proteins able to inhibit induction and signaling of type-I interferons. However, recent studies have demonstrated that interferons are produced during SARS-CoV infection in humans and macaques. Furthermore, nuclear translocation of activated STAT1 and a range of interferon-stimulated genes could be demonstrated in the lungs of SARS-CoV-infected macaques. In line with these observations, plasmacytoid dendritic cells have been shown to produce interferons upon SARS-CoV infection in vitro. Given the pivotal role of interferons during viral infections, (differential) induction of interferons may affect the outcome of the infection. Therefore, the functional implication of interferon production during SARS-CoV infection remains to be re-investigated.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">19885368</PMID>
<DateRevised><Year>2019</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1746-0794</ISSN>
<JournalIssue CitedMedium="Print"><Volume>4</Volume>
<Issue>1</Issue>
<PubDate><Year>2009</Year>
<Month>Jan</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Future virology</Title>
<ISOAbbreviation>Future Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>Unraveling the complexities of the interferon response during SARS-CoV infection.</ArticleTitle>
<Pagination><MedlinePgn>71-78</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Viruses employ different strategies to circumvent the antiviral actions of the innate immune response. SARS coronavirus (SARS-CoV), a virus that causes severe lung damage, encodes an array of proteins able to inhibit induction and signaling of type-I interferons. However, recent studies have demonstrated that interferons are produced during SARS-CoV infection in humans and macaques. Furthermore, nuclear translocation of activated STAT1 and a range of interferon-stimulated genes could be demonstrated in the lungs of SARS-CoV-infected macaques. In line with these observations, plasmacytoid dendritic cells have been shown to produce interferons upon SARS-CoV infection in vitro. Given the pivotal role of interferons during viral infections, (differential) induction of interferons may affect the outcome of the infection. Therefore, the functional implication of interferon production during SARS-CoV infection remains to be re-investigated.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Lang</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Baas</LastName>
<ForeName>Tracey</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Smits</LastName>
<ForeName>Saskia L</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Katze</LastName>
<ForeName>Michael G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Osterhaus</LastName>
<ForeName>Albert Dme</ForeName>
<Initials>AD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Haagmans</LastName>
<ForeName>Bart L</ForeName>
<Initials>BL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 HL080621</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 HL080621-01A1</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Future Virol</MedlineTA>
<NlmUniqueID>101278124</NlmUniqueID>
<ISSNLinking>1746-0794</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19885368</ArticleId>
<ArticleId IdType="doi">10.2217/17460794.4.1.71</ArticleId>
<ArticleId IdType="pmc">PMC2680287</ArticleId>
<ArticleId IdType="mid">NIHMS88172</ArticleId>
</ArticleIdList>
<pmc-dir>nihms</pmc-dir>
        <ReferenceList><Reference><Citation>Paediatr Respir Rev. 2004 Dec;5(4):275-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15531251</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2005 Oct 1;106(7):2366-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15860669</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15657466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Jun 15;174(12):7977-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15944304</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Sep;81(18):9812-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17596301</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2004 Mar;10 (3):290-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2006 Sep 30;353(2):474-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16860835</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Feb;79(4):2079-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15681410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12885-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16912115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030519</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Sep 1;175(5):2851-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16116171</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Jun;80(12):5927-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16731931</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Jan;80(2):785-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16378980</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2003 May;4(5):491-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12692549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>World J Gastroenterol. 2005 Aug 28;11(32):5037-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16124062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17264-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15563593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 May 17;361(9370):1701-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12767737</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2006 Mar 15;107(6):2423-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16293610</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S207-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15577575</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cytokine. 2005 Oct 7;32(1):30-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16129616</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2005 May 13;280(19):18651-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15767254</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Immunol. 2005 Jan 18;6:2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655079</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2006 May 4;441(7089):101-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2006 Jul;87(Pt 7):1953-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16760397</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2007 Aug;27(2):240-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17723216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 May;79(10):6180-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15858003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2004 Jul;5(7):730-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15208624</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cytokine Growth Factor Rev. 2008 Feb;19(1):3-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18248767</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 May 4;342(18):1334-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10793167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 2004 Aug;72(8):4410-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15271897</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2007 Feb 1;109(3):1131-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16985170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2005 Oct 10;341(1):163-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16095648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2007 Aug 10;3(8):e112</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17696609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Life Sci. 2004 Aug;61(16):2100-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15316659</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 May;80(10):5059-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16641297</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Immunol. 2004 Mar;135(3):467-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15008980</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Oct;78(20):11416-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15452265</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2007 Apr 25;361(1):18-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17316733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jan;81(2):548-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17108024</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Jun;10(6):1030-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15207054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2008 Apr;133(1):101-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17451827</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2005 Feb;75(2):185-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15602737</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Aug;81(16):8692-706</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17537853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biochem Mol Biol. 2004 Nov 30;37(6):635-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15607020</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Nov;79(21):13800-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16227300</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2006 Dec 1;177(11):8008-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17114474</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2007 May 25;282(21):15325-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17395583</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Oct;82(19):9465-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18632870</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2007 Mar 9;282(10 ):7576-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17204473</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001802 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001802 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:19885368
   |texte=   Unraveling the complexities of the interferon response during SARS-CoV infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:19885368" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Unraveling the complexities of the interferon response during SARS-CoV infection.

Unraveling the complexities of the interferon response during SARS-CoV infection.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki